Brammer Bio Expands Leadership Team for Commercial Readiness |
| March 20, 2018 | March 2018 Bond Updates |
|
CAMBRIDGE, Mass., March 20, 2018 /PRNewswire/ -- Brammer Bio ("Brammer"), a best-in-class viral vector contract development and manufacturing organization (CDMO) for companies developing gene-modified cell therapies and in vivo gene therapies, announces recent leadership appointments to... |
| View more at: https://www.prnewswire.com/news-releases/brammer-bio-expands-leadership-team-for-commercial-readiness-300615419.html |
| Related News |
|